Skip to main content

[Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments].

Publication ,  Journal Article
Gersh, BJ; Freedman, JE; Granger, CB
Published in: Rev Esp Cardiol
April 2011

Duke Scholars

Published In

Rev Esp Cardiol

DOI

EISSN

1579-2242

Publication Date

April 2011

Volume

64

Issue

4

Start / End Page

260 / 268

Location

Spain

Related Subject Headings

  • Warfarin
  • Vitamin K
  • Thromboembolism
  • Thrombin
  • Stroke
  • Platelet Aggregation Inhibitors
  • Humans
  • Fibrinolytic Agents
  • Factor Xa Inhibitors
  • Evidence-Based Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gersh, B. J., Freedman, J. E., & Granger, C. B. (2011). [Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments]. Rev Esp Cardiol, 64(4), 260–268. https://doi.org/10.1016/j.recesp.2011.01.001
Gersh, Bernard J., Jane E. Freedman, and Christopher B. Granger. “[Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments].Rev Esp Cardiol 64, no. 4 (April 2011): 260–68. https://doi.org/10.1016/j.recesp.2011.01.001.
Gersh, Bernard J., et al. “[Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments].Rev Esp Cardiol, vol. 64, no. 4, Apr. 2011, pp. 260–68. Pubmed, doi:10.1016/j.recesp.2011.01.001.

Published In

Rev Esp Cardiol

DOI

EISSN

1579-2242

Publication Date

April 2011

Volume

64

Issue

4

Start / End Page

260 / 268

Location

Spain

Related Subject Headings

  • Warfarin
  • Vitamin K
  • Thromboembolism
  • Thrombin
  • Stroke
  • Platelet Aggregation Inhibitors
  • Humans
  • Fibrinolytic Agents
  • Factor Xa Inhibitors
  • Evidence-Based Medicine